Gesynta Pharma AB

Gesynta Pharma is a Swedish pharmaceutical company that develops unique drug candidates with the aim to reduce harmful inflammation and increase blood flow in the body’s microvasculature, thereby providing safe and efficacious treatments for several serious diseases. In a short time, Gesynta Pharma’s strong management team and renowned board of directors have combined excellence in research and development with suave entrepreneurship to build a robust scientific platform and clinical pipeline. With a portfolio of drug candidates with the unique capability to reduce inflammation and protect blood vessels, Gesynta Pharma stands well prepared for its continued value creation.